VACOP-B vs VACOP-B plus high-dose sequential therapy (RDS) for aggressive non-Hodgkin's lymphoma (NHL).

被引:0
|
作者
Santini, G [1 ]
Olivieri, A [1 ]
Majolino, I [1 ]
Chisesi, T [1 ]
Salvagno, L [1 ]
Biglio, A [1 ]
de Souza, C [1 ]
Congiu, M [1 ]
Rizzoli, V [1 ]
机构
[1] Osped San Martino Genova, Dept Haematol, Genoa, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3576
引用
收藏
页码:862A / 862A
页数:1
相关论文
共 50 条
  • [41] High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma
    Ballestrero, A
    Clavio, M
    Ferrando, F
    Gonella, R
    Garuti, A
    Sessarego, M
    Ghio, R
    Gobbi, M
    Patrone, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (05) : 1007 - 1013
  • [42] Treatment of high-risk non-Hodgkin lymphoma with intensified induction therapy and high-dose sequential therapy
    Rigacci, L.
    Puccini, B.
    Nassi, L.
    Guidi, S.
    Alterini, R.
    Mappa, S.
    Lombardini, L.
    Bernardi, F.
    Nozzoli, C.
    Carrai, V.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S319 - S320
  • [43] Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? For
    Behr, TM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (09) : 1248 - 1254
  • [44] Is high-dose radioimmunotherapy needed in non-Hodgkin’s lymphoma?
    Thomas M. Behr
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 1248 - 1254
  • [45] Reduced relative dose intensity (RDI) in patients with aggressive non-Hodgkin's lymphoma (NHL).
    Dale, DC
    Goldschmidt, JH
    Crawford, J
    Lyman, GH
    BLOOD, 2004, 104 (11) : 905A - 906A
  • [46] Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
    Horwitz, SM
    Negrin, RS
    Blume, KG
    Breslin, S
    Stuart, MJ
    Stockerl-Goldstein, KE
    Johnston, LJ
    Wong, RM
    Shizuru, JA
    Horning, SJ
    BLOOD, 2004, 103 (03) : 777 - 783
  • [47] High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma
    Wang, WS
    Tzeng, CH
    Chiou, TJ
    Liu, JH
    Hsieh, RK
    Yen, CC
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 154 - 157
  • [48] BP-VACOP and extensive lymph node irradiation (RT) in the treatment of advanced stage low grade non-Hodgkin's lymphoma (NHL) at diagnosis.
    Gill, KK
    Klasa, RJ
    Hoskins, PJ
    O Reilly, SE
    Fairey, R
    Voss, NJ
    Gascoyne, RD
    Connors, JM
    BLOOD, 2000, 96 (11) : 134A - 134A
  • [49] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [50] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma
    Kriegsmann, Katharina
    Rieger, Michael
    Schwarzbich, Mark-Alexander
    Sitter, Soeren
    Kriegsmann, Mark
    Bruckner, Thomas
    Hensel, Manfred
    Ho, Anthony Dick
    Witzens-Harig, Mathias
    Wuchter, Patrick
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 12 - 20